Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (300534.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap2.88B
Enterprise Value2.79B
P/E Ratio51.23
PEG Ratio0.82
Price/Sales Ratio2.74
Price/Book Ratio3.1
Enterprise/Revenue2.65
Enterprise/EBITDA19.24

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.05
Operating Margin0.1
AD

Management Effectiveness

Return On Assets0.03
Return On Equity0.06

Income Statement

Revenue877.85M
Revenue/Share2.73
Gross Profit584.11M
EBITDA126.91M
Net Income43.95M
Diluted EPS0.14

Balance Sheet

Total Cash234.61M
Total Cash/Share0.77
Total Debt155.45M
Total Debt/Equity0.21
Current Ratio1.54
Book Value Per Share2.68

Price History

52-Week Change-25.89
52-Week High12.9
52-Week Low6.78
Moving Average 50 Days8.08
Moving Average 200 Days9.44

Statistics

Average Volume6.09M
Shares Outstanding303.35M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.04
Trailing Annual Dividend Yield0.53
Payout Ratio0.06
Last Split Factor7:2
Last Split DateMay 10, 2017
AD